Showing results (261-270 of 307) with videos related to
Sort By:
Pageof 31
The Journal of Antimicrobial Chemotherapy|April 30, 2015
Mitochondrial and apoptotic in vitro modelling of differential HIV-1 progression and antiretroviral toxicityC Morén, M Bañó, I González-Casacuberta, et al.The Journal of Antimicrobial Chemotherapy|November 2, 2017
Tenofovir disoproxil fumarate/emtricitabine plus ritonavir-boosted lopinavir or cobicistat-boosted elvitegravir as a single-tablet regimen for HIV post-exposure prophylaxisA Inciarte, L Leal, E González, et al.Annals of Surgery|April 1, 1996
A clinical trial on the prevention of catheter-related sepsis using a new hub modelM Segura, F Alvarez-Lerma, J M Tellado, et al.AIDS (London, England)|January 11, 2000
Comparison of twice-daily stavudine plus once- or twice-daily didanosine and nevirapine in early stages of HIV infection: the scan studyF García, H Knobel, M A Sambeat, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000
Dose-finding study of once-daily indinavir/ritonavir plus zidovudine and lamivudine in HIV-infected patientsJ Mallolas, J L Blanco, M Sarasa, et al.The Journal of Antimicrobial Chemotherapy|June 5, 2007
Hospital-acquired pneumonia guidelines in Europe: a review of their status and future developmentR Masterton, D Craven, J Rello, et al.International Journal of Antimicrobial Agents|July 4, 2017
Drivers and impact of antifungal therapy in critically ill patients with Aspergillus-positive respiratory tract culturesJ A Paiva, P Mergulhão, A Gomes, et al.Antiviral Therapy|April 1, 1996
A pilot case-control study of zidovudine compared with zidovudine plus didanosine in patients with advanced HIV-1 disease and no previous experience with antiretroviralsJ M Gatell, M Leal, J Mallolas, et al.Intensive Care Medicine|November 26, 2010
Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infectionI Martin-Loeches, T Lisboa, A Rhodes, et al.HIV Clinical Trials|April 19, 2012
Longer prior exposure to zidovudine/lamivudine-containing combination antiretroviral therapy, age, and male gender are each associated with reduced subcutaneous adipose tissueS M E Vrouenraets, F W N M Wit, E Fernandez Garcia, et al.Pageof 31